1/20/2022 | 3004900002 | MEDICINES FOR USE FOR THERAPEUTIC/PROPHYLAXIC PURPOSES, PACKED AS DOSED DOSAGE FORMS, ARE IMPORTED AS SAMPLES ON A FREE BASIS FOR CLINICAL STUDIES UNDER OSE-127-C201 PROTOCOL | 4.6 | 1189.82 | Switzerland | MOSCOW RUSSIA | WORLDWIDE CLINICAL TRAILS LLC |
1/30/2022 | 3004900008 | MEDICINES FOR CLINICAL STUDIES ACCORDING TO PROTOCOL No. CBYL719C2202, COMP. FROM MIXED PRODUCTS, FOR USE. FOR THERAPEUTIC / PREVENTIVE PURPOSES, PACKED IN THE FORM OF DOSE. MEDICINE. FORMS, NOT FOR VETERINARY, NOT SOD. ETHYL | 7.7 | 169760.2 | Switzerland | Unknown | NOVARTIS PHARMA LLC |
1/29/2022 | 3004900002 | MEDICAL DEVICE IN RETAIL PACKAGING, VISCOELASTIC STERILE IMPLANT ARTHROVISC 40 KIT FOR INTRA-ARTULAR INJECTIONS IN SYRINGE (ARV-HA40-3) FOR THERAPEUTIC PURPOSES IN DISEASES OF THE JOINTS, WITHOUT | 61.7 | 20356.6 | Switzerland | MONSUR LAUSANNE | CORPORATION OF AESTHETIC MEDICINE LLC |
1/30/2022 | 3004900008 | MEDICINES FOR CLINICAL STUDIES ACCORDING TO PROTOCOL No. CLDK378A2X01B, CONSISTING OF MIXED PRODUCTS FOR USE IN THERAPEUTIC / PREVENTIVE PURPOSES, PACKED IN THE FORM OF DOSE. MEDICINE. FORM; NOT FOR SALE, NOT FOR | 5.4 | 49537.4 | Switzerland | Unknown | NOVARTIS PHARMA LLC |
1/24/2022 | 3004900008 | MEDICINES FOR CLINICAL STUDIES ACCORDING TO PROTOCOL No. CABL001A2301, CONSISTING OF MIXED PRODUCTS, FOR USE. FOR THERAPEUTIC OR PREVENTIVE PURPOSES, PACKED IN THE FORMS OF DOSAGE; NOT FOR SALE, NOT FOR | 0.54 | 480.16 | Switzerland | Unknown | NOVARTIS PHARMA LLC |